Fidelity Investments’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Fidelity Investments’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-90,259	Closed	-$2.11M	–	5186
2021 Q1	$2.11M	Hold	90,259	–	–	﹤0.01%	2461
2020 Q4	$2.6M	Sell	90,259 -304,505	-77%	-$7.67M	﹤0.01%	2341
2020 Q3	$8M	Sell	394,764 -313,493	-44%	-$7.65M	﹤0.01%	1897
2020 Q2	$21.3M	Sell	708,257 -626,507	-47%	-$22.6M	﹤0.01%	1525
2020 Q1	$42M	Sell	1,334,764 -246,951	-16%	-$8.59M	0.01%	1100
2019 Q4	$74.5M	Buy	1,581,715 +446,328	+39%	+$12.9M	0.01%	1032
2019 Q3	$7.33M	Sell	1,135,387 -239,077	-17%	-$2M	﹤0.01%	1932
2019 Q2	$16.9M	Sell	1,374,464 -199,781	-13%	-$2.22M	﹤0.01%	1691
2019 Q1	$21.3M	Sell	1,574,245 -200	-0%	-$1.79K	﹤0.01%	1582
2018 Q4	$6.13M	Sell	1,574,445 -44,100	-3%	-$266K	﹤0.01%	1963
2018 Q3	$10.3M	Buy	+1,618,545	New	+$15.4M	﹤0.01%	1924

Other funds holding CNST

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return

Ponoi Management San Francisco, California $73.2M AUM 23.44% 1-Year Est. Return

OPU

Omni Partners US Irvine, California $1.95B AUM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

PIM

Ponoi II Management San Francisco, California $38.3M AUM 32.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments's CNST Position: Q2 2021 in Review

Fidelity Investments sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q2 2021, closing a stake of 90,259 shares — an estimated $2.11M sold.

Fidelity Investments first reported a position in CNST in Q3 2018 and held it in 11 quarters. The position peaked at $74.5M in Q4 2019. 153 funds tracked by Wall St. Rank hold CNST as of Q2 2021.

Fidelity Investments reported no remaining Constellation Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
Fidelity Investments sold 90,259 Constellation Pharmaceuticals, Inc. shares in Q2 2021, an estimated $2.11M.
Fidelity Investments first reported a position in Constellation Pharmaceuticals, Inc. in Q3 2018 and held it in 11 quarters.
Fidelity Investments's Constellation Pharmaceuticals, Inc. position peaked at $74.5M in Q4 2019.
153 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q2 2021.

Based on Fidelity Investments's 13F filing for Q2 2021, filed 13 Aug 2021.